STRIDES ANNOUNCES SUCCESSFUL COMPLETION OF US FDA INSPECTION AT ITS FLAGSHIP FACILITY IN BANGALORE

0
14

Bangalore, 2nd November  2018: Strides Pharma Science Limited (Strides)today announced that its formulations facility in Bangalore recently underwent a USFDA inspection that ended on November 2, 2018. The inspection was completed successfully with Zero 483 observations.

The facility (KRS Gardens) in Bangalore is the largest facility for the company and has the capability in several dosage formats including tablets, capsules (both hard gelatin and soft gelatin), ointments, creams, and liquids. The facility supports several important current and future submissions for the US Market.